Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

Hereditary Cancer in Clinical Practice

Volumn 5, Issue 3, 2007, Pages 161-163

  McKinley, Joanne M ^a   Weideman, Prue C ^a   Jenkins, Mark A ^b   Friedlander, Michael L ^c   Hopper, John L ^b   McLachlan, Sue Anne ^a,b,d   Lindeman, Geoffrey J ^e   Phillips, Kelly Anne ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

BRCA1; BRCA2; Prostate; Screening

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PROSTATE CANCER;

EID: 35348847750     PISSN: 17312302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Doherty R, Lubinski J, Manguoglu E, Luleci G, Christie M, Craven P, Bancroft E, Mitra A, Morgan S, Eeles R, on behalf of the IMPACT steering committee and collaborators. Short Report. The AIDIT and IMPACT conference 2006: Outcomes and future directions. Hereditary Cancer Clin Pract 2007; 5: 53-55.
2. Liede A, Metcalfe K, Hanna D, Hoodfar E, Snyder C, Durham C, Lynch HT, Narod SA. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am J Hum Genet 2000; 67: 1494-1504.
3. Phillips KA, Butow PN, Stewart AE, Change JH, Weideman PC, Price MA, McLachlan SA, kConFab Investigators, Lindeman GJ, McKay MJ, Friedlander ML, Hopper JL kConFab Investigators. Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer 2005; 4: 105-113.
4. Kathleen Cuningham Consortium for Research into Familial Breast Cancer. kConFab (homepage on the internet). www.kconfab.org.
5. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006; 8: R12.
6. Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinley JM, Weideman PC, Hopper JL, Friedlander ML; kConFab Investigators. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet 2006; 70: 198-206.
7. Familial aspects of cancer: a guide to clinical practice. Canberra, Biotext, NHMRC, 1999.